EFTA01006126.pdf

From: "Jeffrey E." <[email protected]> To: Subject: Re: Upsized breast implant IPO: Establishment Labs prices IPO above the range at $18 - Nasdaq.com Date: Thu, 19 Jul 2018 05:25:06 +0000 Great On Wed, Jul 18, 2018 at 11:33 PM > wrote: Going public tomorrow! https://m.nasdaq.com/article/upsized-breast-implant-ipo-establishment-labs-prices-ipo-above-the-range-at-18- cm993240 Upsized breast implant IPO: Establishment Labs prices IPO above the range at $18 Renaissance Capital RiFeaturod Image Establishment Labs Holdings, a fast-growing provider of silicone breast implants outside the US, raised $67 million in an upsized offering of 3.7 million shares at $18, above the range of $15 to $17. The company originally filed to offer 3.1 million shares. Establishment Labs plans to list on the Nasdaq under the symbol ESTA. Jefferies and Cowen acted as lead managers on the deal. The article Upsized breast implant IPO: Establishment Labs prices IPO above the range at $18 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com. Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned. EFTA01006126  The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc. This message is directed to and is for the use of the above-noted addressee only, and its contents may be legally privileged or confidential. If the reader of this message is not the intended recipient, you are hereby notified that any distribution, dissemination, or copy of this message is strictly prohibited. If you have received this message in error, please delete it immediately and notify the sender. This message is not intended to be an electronic signature nor to constitute an agreement of any kind under applicable law unless otherwise expressly indicated hereon. please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01006127